Literature DB >> 6935293

Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

K Ozato, D H Sachs.   

Abstract

Eleven hybridoma antibodies directed against mouse major histocompatibility complex products of the H-2b haplotype have been produced and characterized. Of 7 antibodies reacting to H-2Kb and/or H-2Db antigens, all cross-reacted with other H-2 antigens, and 5 exhibited no correspondence with a known H-2 specificity established in the H-2 chart. Four anti-Iab antibodies all reacted with antigens encoded by the I-A subregion. Some of these antibodies showed no cross-reaction with other haplotypes, indicating reactions to private specificities of the I-Ab antigen. In addition, these anti-Ia antibodies appeared to be capable of distinguishing fine determinant differences, which corresponding alloantisera failed to reveal. A high frequency of hybridomas secreting IgM antibodies was found after fusions of spleen cells obtained from C3H anti-C3H.SW immunized mice, in contrast to the dominance of IgG hybridomas produced previously by fusions of spleen cells from mice immunized in the reverse direction. An isotype analysis of conventional cytotoxic alloantisera from the same strain combinations was therefore performed. The same correlation with respect to isotype expression was found, indicating that hybridoma antibodies reflect normal antibody responses and suggesting H-2-linked control of this expression.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6935293

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  231 in total

1.  Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

Authors:  J Karttunen; S Sanderson; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  CD4-CD8+ T-cell receptor-alpha beta+ major histocompatibility complex class-II-specific T-cell clones isolated from aged athymic mice.

Authors:  K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

3.  Positive selection of Tcrb-V10b+ T cells.

Authors:  K Tomonari; R Hederer; H Hengartner
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.

Authors:  Alberto Diaz-Quiñonez; Natalia Martin-Orozco; Armando Isibasi; Vianney Ortiz-Navarrete
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Oral administration of antigen does not influence the proliferation and IFN-γ production of responsive CD8+ T cells but enables to establish T cell clones with different lymphokine production profile.

Authors:  K Nishijima; T Hisatsune; H Kato; M Kohyama; M Kakehi; S Hachimura; S Kaminogawa
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

6.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.

Authors:  K L Rock; L E Rothstein; S R Gamble; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Surface appearance and instability of empty H-2 class I molecules under physiological conditions.

Authors:  V Ortiz-Navarrete; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Positive selection of Tcrb-V4+CD8+ T cells by H-2d molecules.

Authors:  K Tomonari; S Fairchild
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Transfected rat islet tumour cells express mouse major histocompatibility complex class I antigens functionally. Applicable as "pseudo-syngeneic" targets in the multiple low-dose streptozotocin diabetes model.

Authors:  P Serup; J Schøller
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

10.  Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia.

Authors:  L L Perry; M Miyazawa; K Hasenkrug; K Wehrly; C S David; B Chesebro
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.